Cartesian Therapeutics, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2018-06-15

Reporting Person: HUTT PETER BARTON (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-15	Stock Option (Right to Buy)	$12.75	A	10000	Acquired	2028-06-14	Common Stock (10000)	Direct

Footnotes

F1: The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders.